匹伐他汀钙，CAS 登记号 147526-32-7，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 匹伐他汀钙 的 CAS 号：147526-32-7，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
Pitavastatin calcium · CAS 147526-32-7 · C50H46CaF2N2O8. UNII IYD54XEG3W.
| CAS Registry Number | 147526-32-7 |
|---|---|
| PubChem CID | 5282451 |
| Molecular formula | C50H46CaF2N2O8 |
| IUPAC name | calcium bis((E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate) |
| UNII (FDA) | IYD54XEG3W |
| Molecular Weight | 881.0 |
|---|---|
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 14 |
| Exact Mass | 880.2848136 |
| Monoisotopic Mass | 880.2848136 |
| Topological Polar Surface Area | 187 |
| Heavy Atom Count | 63 |
| Formal Charge | 0 |
| Complexity | 626 |
| GHS notification summary | 11.1% (1 / 9) |
|---|
| GHS notification summary | 11.1% (1 / 9) |
|---|---|
| Reported hazard statements | H301 (22.2%), H302 (55.6%), H360 (11.1%), H361 (11.1%), H362 (22.2%), H370 (11.1%), H372 (11.1%), H373 (11.1%) |
This chemical does not meet GHS hazard criteria for 11.1% (1 of 9) of reports.
H301 (22.2%): Toxic if swallowed [Danger Acute toxicity, oral]
Pitavastatin calcium; 147526-32-7; Livalo; Pitavastatin hemicalcium; Itavastatin calcium; Pitavastatin calcium salt; DTXSID4046448; IYD54XEG3W; CHEBI:71258; DTXCID40819916; RefChem:56352; Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate; MFCD01937979; calcium (E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate; calcium;(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate; PITAVASTATIN CALCIUM [ORANGE BOOK]
CAS 147526-32-7; molecular formula C50H46CaF2N2O8; molecular weight — g/mol.
Pitavastatin calcium, 147526-32-7, Livalo, Pitavastatin hemicalcium, Itavastatin calcium, Pitavastatin calcium salt.
11.1% of GHS notifications report no hazard classification (1 of 9).
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.